Keller Rohrback Investigates Overcharges for Hepatitis C Drugs
January 27, 2017
According to the results of a recent congressional inquiry, Gilead Sciences Inc.—the maker of the two popular drugs for hepatitis C patients, Sovaldi and Harvoni—chose to pursue “high list prices for the drugs instead of trying to make the treatments widely available.” The report goes on to explain that despite being “fully aware” that it would make the drug unaffordable for many patients, the company priced a 12-week course of Sovaldi and Harvoni at $84,000 and $94,500, respectively.
In response to market pressure and public outcry over the drug’s prohibitively high prices, in February 2015, the company began to offer discounts on Sovaldi and Harvoni aimed at reducing the cost of those drugs by up “to 46%, on average.” Keller Rohrback L.L.P., a leader in representing consumers in class action lawsuits, is investigating whether those savings have been passed on to patients and their health plans or kept by Pharmacy Benefits Managers (“PBM”s), insurance industry middle-men who negotiate prices with drug manufacturers and oversee prescription drug plans on behalf of insurance providers and corporations.
If you take Sovaldi or Harvoni and are enrolled in a prescription drug plan—or if you are the sponsor of a plan offering those drugs—you may be overpaying for these medications and losing out on significant rebates offered by drug manufacturers to make the medication more affordable. If you would like to know more or discuss Keller Rohrback’s investigation, please contact attorneys Gretchen Obrist or Michael Meredith at (800) 776-6044 or via email at email@example.com
Keller Rohrback L.L.P. has decades of experience helping consumers and insureds fight back against fraud and abuse. Keller Rohrback L.L.P. serves as lead and co-lead counsel in class action lawsuits throughout the country. With offices in New York, Seattle, Phoenix, Ronan, Oakland, and Santa Barbara, our Complex Litigation Group is proud to offer its expertise to clients nationwide. Our trial lawyers have obtained judgments and settlements on behalf of clients in excess of eighteen billion dollars.